13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.
Glaxosmithkline
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.
Glaxosmithkline
Discovery of Potent Inhibitors of Schistosoma mansoni NAD¿ Catabolizing Enzyme.
University of Strasburg
Cyclic adenosine 5'-diphosphate ribose analogs without a"southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
University of Bath
Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy.
Immunophage Biotech Co.
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.
Elixir Pharmaceuticals
2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships.
Glaxosmithkline Research and Development
LONG-CHAIN COMPOUND THAT ACTS ON ACLY, PREPARATION METHOD THEREFOR AND USE THEREOF
Shanghaiinstitute of Materia Medica
Dizocilpine derivatives as peripheral NMDA receptor antagonists
Institut National De La Sante Et De La Recherche Medicale (Inserm